[Ile5,Trp23]PTHrP-(2-36) (human)



[Ile5,Trp23]PTHrP-(2-36) (human)

V1VV1S2SS2E3EE3I4II4Q5QQ5L6LL6L7LL7H8HH8D9DD9K10KK10G11GG11K12KK12S13SS13I14II14Q15QQ15D16DD16L17LL17R18RR18R19RR19R20RR20F21FF21W22WW22L23LL23H24HH24H25HH25L26LL26I27II27A28AA28E29EE29I30II30H31HH31T32TT32A33AA33E34EE34I35II35

SMILES None
InChIKey None
Sequence VSEIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

[Ile5,Trp23]PTHrP-(2-36) (human)

V1VV1S2SS2E3EE3I4II4Q5QQ5L6LL6L7LL7H8HH8D9DD9K10KK10G11GG11K12KK12S13SS13I14II14Q15QQ15D16DD16L17LL17R18RR18R19RR19R20RR20F21FF21W22WW22L23LL23H24HH24H25HH25L26LL26I27II27A28AA28E29EE29I30II30H31HH31T32TT32A33AA33E34EE34I35II35

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.